Page last updated: 2024-12-06
2,2'-disulfohexanoic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2,2'-disulfohexanoic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 31174 |
SCHEMBL ID | 9068438 |
MeSH ID | M0059130 |
Synonyms (15)
Synonym |
---|
22414-91-1 |
2,2'-disulfohexanoic acid |
8uft3c5wka , |
hexanoic acid, 2,2'-dithiobis-, calcium salt (1:1) |
unii-8uft3c5wka |
einecs 244-976-8 |
2,2'-dithiobishexanoic acid |
es-914 |
hexanoic acid, 2,2'-dithiobis- |
hexanoic acid, 2,2'-dithiodi- |
.alpha.,.alpha.'-dithiodicaproic acid |
SCHEMBL9068438 |
2,2'-disulfanediyldihexanoic acid |
DTXSID30945071 |
Q27271031 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.06) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (16.67%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |